| Literature DB >> 18053014 |
F E R Simons1, A J Frew, I J Ansotegui, B S Bochner, D B K Golden, F D Finkelman, D Y M Leung, J Lotvall, G Marone, D D Metcalfe, U Müller, L J Rosenwasser, H A Sampson, L B Schwartz, M van Hage, A F Walls.
Abstract
Effector mechanisms in anaphylaxis were reviewed. Current approaches to confirmation of the clinical diagnosis were discussed. Improved methods for distinguishing between allergen sensitization (which is common in the general population) and clinical risk of anaphylaxis (which is uncommon) were deliberated. Innovative techniques that will improve risk assessment in anaphylaxis in the future were described.Entities:
Mesh：
Year: 2008 PMID： 18053014 DOI： 10.1111/j.1398-9995.2007.01605.x
Source DB: PubMed Journal: Allergy ISSN： 0105-4538 Impact factor: 13.146